"source","timestamp","newsProvider","x.prHeadline","x.headlineTxt","x.namedEntity","completeTxt"
"https://www.prnewswire.com/news-releases/ira-capital-launches-flagship-500-million-healthcare-real-estate-fund-301899253.html","12 Aug, 2023, 15:27 ET","
News provided by

IRA Capital



12 Aug, 2023, 15:27 ET
","IRA Capital Launches Flagship $500 Million Healthcare Real Estate Fund","Aug 12, 2023, 15:27 ETIRA Capital Launches Flagship $500 Million Healthcare Real Estate FundIRA will be leveraging its compelling track record in healthcare real estate, which has averaged a net 48% annualized return and a net 1.7x equity multiple to its investors. IRA has been among the most active healthcare real estate investors in the United States. The firm has demonstratedMore news about: IRA Capital","IRA Capital","IRVINE, Calif., Aug, 12, 2023 /PRNewswire/ -- IRA Capital (""IRA""), a leading Southern-California based private equity firm, has announced the launch of IRA Healthcare Real Estate Fund, L.P. (the ""Fund"") <U+2013> a $500 Million closed-end fund focused on the acquisition of medical properties and senior housing assets across the United States. IRA will be leveraging its compelling track record in healthcare real estate, which has averaged a net 48% annualized return and a net 1.7x equity multiple to its investors. IRA has been among the most active healthcare real estate investors in the United States. The firm has demonstrated its ability to execute at scale over the past 13 years, having exited numerous investments to some of the largest institutions and public REITS. IRA sold a 19-property portfolio for approximately $300 Million to Welltower REIT in January 2020 and another 29-property portfolio for approximately $620 Million to Nuveen Real Estate in August 2021.Having built one of the most reputable privately held healthcare real estate platforms in the country, IRA has established extensive relationships with health systems and medical providers. The firm has successfully utilized its relationships to source attractive opportunities and aggregate best-in-class assets. ""Our firm's expertise and exceptional track record in this niche asset class combined with strong secular trends uniquely positions us to deliver strong risk-adjusted returns for the Fund"" says Amer Kasm, co-founder at IRA Capital. The Fund will focus on the acquisition, development, and financing of well-located healthcare assets in high barrier-to-entry and supply-constrained markets. IRA's principals will be co-investing alongside existing and new investors. The offering will be open to domestic and foreign endowments, pension funds, insurance companies, family offices, fund of funds, registered investment advisors, and other qualified high net-worth investors. Investors will have the opportunity to diversify capital across healthcare assets and geographic markets, with projected annualized net returns of 14%-16% and a net equity multiple of 1.7x-1.9x. According to IRA Capital co-founder Jay Gangwal, ""We intend to acquire assets across the risk spectrum with a focus on core-plus and value-add opportunities. The diverse strategy will result in a balanced portfolio with a combination of yield and appreciation, while providing downside protection given the needs-based demand. The current capital markets environment is also presenting unique re-positioning opportunities that we expect will create significant value and generate outsized returns.""Sidley Austin LLP served as legal counsel in the Fund's formation.About IRA CapitalIRA Capital is a Southern-California based private equity firm founded in 2010 by partners Amer Kasm, Samir Patel, Jay Gangwal, Amer Malas, and Mohannad Malas. IRA invests capital for its own account and on behalf of its co-investment partners, which include pension funds, institutions, and family offices. Headquartered in Irvine California, IRA has acquired over seven million square feet of property in 30 states, with a total capitalization greater than $3 Billion. www.IRAcapital.comFor more information, please contact:Danielle BallCorporate Communications[email protected] / +1.949.258.7411SOURCE IRA Capital"
"https://www.prnewswire.com/news-releases/remote-patient-monitoring-market-to-grow-by-usd-1-733-81-million-between-2022-and-2027-the-emergence-of-digital-healthcare-services-and-healthcare-4-0-drives-the-market-301898146.html","11 Aug, 2023, 18:45 ET","
News provided by

Technavio



11 Aug, 2023, 18:45 ET
","Remote Patient Monitoring Market to grow by USD 1,733.81 million between 2022 and 2027| The emergence of digital healthcare services and healthcare 4.0 drives the market","Aug 11, 2023, 18:45 ETRemote Patient Monitoring Market to grow by USD 1,733.81 million between 2022 and 2027| The emergence of digital healthcare services and healthcare 4.0 drives the marketKey drive such as the emergence of digital healthcare services, the concept of Healthcare 4.0, and the need for healthcare accessibility in remote areas. Integration of electronic devices, smartphones, and advanced medical technology is shaping the healthcare landscape, supported by the adoption of analytics,More news about: Technavio","Technavio","NEW YORK, Aug. 11, 2023 /PRNewswire/ -- Technavio, a leading provider of industry news and insights, is pleased to announce its latest report on the Remote Patient Monitoring Market. The report highlights the estimated growth and forecast for the market between 2022 and 2027, predicting an increase in market size of USD 1,733.81 million and a rise at a CAGR of 22.22%.Continue ReadingTechnavio has announced its latest market research report titled Global Remote Patient Monitoring Market 2023-2027The Key drive such as the emergence of digital healthcare services, the concept of Healthcare 4.0, and the need for healthcare accessibility in remote areas. Integration of electronic devices, smartphones, and advanced medical technology is shaping the healthcare landscape, supported by the adoption of analytics, cloud computing, IoT, and AI. Mobile health is a prominent trend, delivering healthcare through mobile devices and addressing aging populations and chronic diseases.YoY growth 2022-2023(%) 21.01 % Key Countries North America, Europe, Asia, and Rest of World (ROW) The report provides a comprehensive insight into the market segmentation by product (vital signs and implantable), end-user (hospitals, ASCs, and home care), and geography (North America, Europe, Asia, and Rest of World (ROW)). This segmentation provides a comprehensive view of the market, encompassing diverse communication solutions and regions. Furthermore, it examines key trends shaping the companies landscape and identifies potential challenges faced by market players. To get insights into the key trends, download the sample report here!The major Remote Patient Monitoring Market companies include Abbott Laboratories, Advantech Co. Ltd., Alten SA, Boston Scientific Corp., Caretaker Medical NA, Draegerwerk AG and Co. KGaA, Honeywell International Inc., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, Napier Healthcare Solutions Pte Ltd. Nihon Kohden Corp. OMRON Corp., OSI Systems Inc. and OSP Labs.These companies are actively implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product launches, to enhance their presence and competitiveness in Remote Patient Monitoring Market.The global remote patient monitoring market is driven by the convergence of digital healthcare services, the emergence of Healthcare 4.0, and the imperative to extend healthcare access to remote areas. The integration of electronic devices, smartphones, and advanced medical technology is reshaping the healthcare landscape through innovations like analytics, cloud computing, IoT, and AI. The rising trend of mobile health addresses the needs of aging populations and those with chronic illnesses. However, challenges persist due to inconsistent reimbursement policies. North America, with its heightened awareness and accelerated demand due to the COVID-19 pandemic, is set to be a significant contributor to this market's expansion.Technavio provides a report that includes competitive intelligence, highlighting major players' key developments and growth strategies, enabling stakeholders to make informed decisions and stay competitive in the market. To buy the complete report on Remote Patient Monitoring Market, click here.Below, are other reports you might be interested with:Patient Monitoring Equipment Market: The Global Patient Monitoring Equipment Market size is estimated to grow at a CAGR of 8.48% between 2022 and 2027. The market size is forecast to increase by USD 20.39 billion. This report covers clinical mass market segmentation by end-user (hospitals, clinics, and ambulatory care services), type (bed-side patient monitoring equipment and remote patient monitoring equipment), and geography (North America, Europe, Asia, and the Rest of World (ROW)).Multiparameter Patient Monitoring Equipment Market: The multiparameter patient monitoring equipment market size will decline by USD 1.51 billion during 2020-2024, and the market's growth momentum will decelerate during the forecast period. The report covers artificial intelligence (AI) in social media market segmentation by product (high-acuity monitors, mid-acuity monitors, and low-acuity monitors) and geography (North America, Europe, APAC, and ROW).About Technavio:Technavio is a trusted source for industry news and insights that help businesses stay ahead in today's competitive landscape. With a team of experienced analysts and researchers, we continuously scrutinize and evaluate the dynamic landscape of markets across the globe. Our comprehensive coverage, meticulous research methodologies, and pragmatic industry expertise have earned us the trust and reliance of a vast clientele, including over 100 esteemed Fortune 500 organizations.SOURCE Technavio"
"https://www.prnewswire.com/news-releases/ais-role-in-modern-healthcare-a-closer-look-at-clinical-practice-301898701.html","11 Aug, 2023, 18:30 ET","
News provided by

Research and Markets



11 Aug, 2023, 18:30 ET
","AI's Role in Modern Healthcare: A Closer Look at Clinical Practice","Aug 11, 2023, 18:30 ETAI's Role in Modern Healthcare: A Closer Look at Clinical PracticeAI in clinical practice and its potential to revolutionize healthcare by enhancing diagnoses, treatment, and clinical workflows.Enhancing Healthcare Through AI:Artificial intelligence (AI) is poised to reshape healthcare by streamlining clinical workflows, addressing staffing challenges,More news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Artificial Intelligence (AI) in Clinical Practice"" report has been added to ResearchAndMarkets.com's offering.This report delves into the use of AI in clinical practice and its potential to revolutionize healthcare by enhancing diagnoses, treatment, and clinical workflows.Enhancing Healthcare Through AI:Artificial intelligence (AI) is poised to reshape healthcare by streamlining clinical workflows, addressing staffing challenges, and improving patient diagnoses and treatment. This report investigates the application of AI in clinical practice across the eight major pharmaceutical markets: US, France, Germany, Italy, Spain, UK, Japan, and China.Key Drivers of AI in Clinical Practice:The report identifies several key drivers that highlight the potential of AI in clinical practice:AI is becoming an integral part of healthcare provision.China is emerging as a leader in adopting AI in healthcare.Physicians with prior AI experience are more supportive of AI integration in clinical practice.AI is more comfortably used for administrative tasks than direct patient care.Healthcare professionals (HCPs) with AI experience are more at ease with personalized AI messaging from sales representatives.Patients' comfort with AI support for clinical decisions is higher among those who have prior AI experience.AI's benefits will require time and strategic implementation.AI is a technology with the potential to mitigate healthcare inflation.Scope of the Report:The report combines data from secondary sources and primary research, including insights from healthcare industry professionals, key opinion leaders (KOLs), and physicians specializing in various therapy areas. The research was conducted between March and June 2023. The study's objectives encompass evaluating the current use of AI in clinical practice, capturing physicians' opinions on AI, identifying areas where AI can optimize clinical practice, exploring future AI prospects, and investigating AI's applications beyond clinical practice.Key Highlights:The report underscores that AI is poised to transform healthcare by enabling improved patient care and clinical processes. The adoption of AI often correlates with hands-on experience and an understanding of the technology. While AI holds significant potential for healthcare enhancement, its implementation requires responsibility and foresight.Companies Mentioned:The report highlights key companies playing a role in AI healthcare advancements, including National Health Service (NHS), World Health Organization (WHO), US Food and Drug Administration (US FDA), Qure.ai Technologies Inc, AstraZeneca, Deloitte, ODAIA, HEVI AI, International Organization for Standardization (ISO), and Hippocratic AI.For more information about this report visit https://www.researchandmarkets.com/r/vk0wcsAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected]For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/global-operating-room-integration-market-research-report-2023-value-set-to-reach-3-7-billion-with-a-cagr-of-12-1-301898693.html","11 Aug, 2023, 17:45 ET","
News provided by

Research and Markets



11 Aug, 2023, 17:45 ET
","Global Operating Room Integration Market Research Report 2023: Value Set to Reach $3.7+ Billion with a CAGR of 12.1%","Aug 11, 2023, 17:45 ETGlobal Operating Room Integration Market Research Report 2023: Value Set to Reach $3.7+ Billion with a CAGR of 12.1%The global operating room integration in the healthcare market is projected to reach USD 3.7 Billion by 2028 from USD 2.1 Billion in 2023, atMore news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Global Operating Room Integration Market by Component (Software, Services), Application (General, Orthopedic, Cardiovascular & Neurosurgery), Device (Audio & Video Systems, Display, Document Management), End User (Hospital, ASC) & Region - Forecast to 2028"" report has been added to ResearchAndMarkets.com's offering.The global operating room integration in the healthcare market is projected to reach USD 3.7 Billion by 2028 from USD 2.1 Billion in 2023, at a high CAGR of 12.1% during the forecast period. OR integration systems are designed to streamline and optimize the surgical workflow. By integrating various devices and systems, these solutions eliminate the need for manual data entry, reduce equipment setup time, and enable seamless communication and coordination among surgical team members. Improved workflow efficiency leads to time savings, reduced errors, and enhanced overall productivity in the operating room. The gradual shift towards predictable outcomes and care quality has supported the greater implementation of various IT systems in healthcare organizations.The Software segment registered the highest CAGR during the forecast period, by deploymentSoftware is projected to register at the highest growth rate in the operating room integration market in 2022. The advent of complex software and the increasing focus on healthcare system integration is expected to drive the demand for operating room integration services in the near future. Additionally, OR integration software offers many benefits, including workflow optimization, device integration, real-time data visualization, communication and collaboration, image and video management, documentation and reporting, Support for training and education, EHR integration, enhanced patient safety, and scalability. It improves efficiency, collaboration, and patient outcomes within the operating room environmentAmbulatory Surgical Centers & clinics is the fastest growing end-user segment in the operating room integration market in 2022Based on the end user, the operating room integration market is into hospitals and ambulatory surgical centers & clinics. In 2022, the ambulatory surgical centers & clinics segment exhibited the fastest growth in the global operating room integration market. The growth of this segment can be attributed to factors such as potential cost reductions, the growing patient population, and the rising demand for better quality of care among patients.APAC to witness the highest growth rate during the forecast periodThe Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the growing prevalence of chronic diseases, the rising adoption of advanced surgical treatment methodologies, the ongoing expansion of the healthcare infrastructure, and the growing market availability of advanced surgical technologies. While the level of OR integration varies across Asia-pacific countries, the overall trend is towards adopting and leveraging these systems to improve surgical practices and enhance patient care. The increasing focus on technology, patient safety, and quality improvement, combined with technological advancements in medical devices and government initiatives, continues to drive the adoption of OR integration in AsiaThe key players functioning in the operating room integration market includeCompanies MentionedAlvo MedicalArthrex, Inc.BarcoBrainlab AgCaresyntaxDitec MedicalDoricon Medical SystemsDragerwerk AG & Co. KGaAEizo GmbHFujifilm Holdings CorporationGetinge AbHill-Rom Holdings, Inc. (Baxter)Isis-SurgimediaKarl Storz Se & Co. KgMeditekMerivaaraOlympus CorporationOpexpark Inc.Richard Wolf GmbHSkytron, LLCSony CorporationSteris plcStryker CorporationTrilux Medical GmbH & Co. Kg (A Subsidiary of Mizuho Osi)Zimmer Biomet Holdings, Inc.Market DynamicsDriversRising Demand for Technologically Advanced SolutionsGrowing Number of Surgical Procedures WorldwideRising Funding Initiatives for the Improvement of Hcit InfrastructureIncreasing Emphasis on Cost Control in HospitalsRestraintsHigh Setup & Operational CostsOpportunitiesGrowth Opportunities in Emerging EconomiesChallengesShortage of Skilled Surgeons in Integrated Operating RoomsInteroperability IssuesFor more information about this report visit https://www.researchandmarkets.com/r/cew0sAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected]For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/artificial-intelligence-ai-market-in-the-education-sector-to-grow-by-usd-1-100-07-million-between-2022-and-2027-increasing-emphasis-on-chatbots-and-ai-as-virtual-assistants-and-its-in-universities-drive-the-market-growth-301898158.html","11 Aug, 2023, 16:30 ET","
News provided by

Technavio



11 Aug, 2023, 16:30 ET
","Artificial Intelligence (AI) Market in the Education Sector to grow by USD 1,100.07 million between 2022 and 2027! increasing emphasis on chatbots and AI as virtual assistants and ITS in universities drive the market growth","Aug 11, 2023, 16:30 ETArtificial Intelligence (AI) Market in the Education Sector to grow by USD 1,100.07 million between 2022 and 2027! increasing emphasis on chatbots and AI as virtual assistants and ITS in universities drive the market growthArtificial Intelligence (AI) Market in the Education Sector in Healthcare Sector: Artificial intelligence (AI) in healthcare market size is estimated to grow at a CAGR of 23.5% between 2022 and 2027. The market size is forecast to increase byMore news about: Technavio","Technavio","NEW YORK, Aug. 11, 2023 /PRNewswire/ -- Technavio, a leading provider of industry news and insights, is pleased to announce its latest report on the Artificial Intelligence (AI) Market in the Education Sector. The report highlights the estimated growth and forecast for the market between 2022 and 2027, predicting an increase in market size of USD 1,100.07 million and a rise at a CAGR of 41.14%.Continue ReadingTechnavio has announced its latest market research report titled Global Artificial Intelligence Market in the Education SectorThe global AI market in the education sector is being propelled by the rising adoption of AI for personalized learning paths, prominently through innovative chatbot integration. These intelligent chatbots, powered by advanced AI and machine learning, engage with students, offer comprehensive responses, and facilitate tailored learning experiences. The increasing emphasis on chatbots as virtual assistants, capable of understanding study patterns and enabling personalized learning pathways, is driving the demand for AI solutions in education.YoY growth 2022-2023(%) 33.25 % Key Countries North America, Europe, APAC, South America, and Middle East and Africa The report provides a comprehensive insight into the market segmentation by end-user (higher education and k-12), learning method outlook (learner model, pedagogical model and domain model) and geography (North America, Europe, APAC, South America, and Middle East and Africa). This segmentation provides a comprehensive view of the market, encompassing diverse communication solutions and regions. Furthermore, it examines key trends shaping the market landscape and identifies potential challenges faced by market players. To get insights into the key trends, download the sample report here!The major Artificial Intelligence (AI) Market in the Education Sector companies include 2U Inc, Alphabet Inc., Amazon.com Inc., Brainly, Carnegie Learning Inc., Century Tech Ltd., Cognii Inc., Cognizant Technology Solutions Corp., DreamBox Learning Inc., Fishtree Inc., International Business Machines Corp., Jenzabar Inc., John Wiley and Sons Inc., Kaltura Inc. and LAIX Inc.These companies are actively implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product launches, to enhance their presence and competitiveness in Artificial Intelligence (AI) Market in the Education Sector.The Artificial Intelligence (AI) Market in the Education Sector growth is driven by the adoption of AI-driven personalized learning paths, prominently through the integration of advanced chatbot technology. These intelligent chatbots not only engage and assist students but also contribute to tailored learning experiences by recognizing individual study patterns. However, the challenge of high implementation costs must be addressed. The impact of the COVID-19 pandemic has further emphasized the value of AI-based educational tools, particularly in the context of remote learning. Going forward, North America's pivotal role, driven by technological advancements and significant investment in AI research for education, underscores the sector's promising transformation. The anticipated growth signifies an exciting evolution in education, where AI stands to revolutionize and elevate the learning journey.Technavio provides a report that includes competitive intelligence, highlighting major players' key developments and growth strategies, enabling stakeholders to make informed decisions and stay competitive in the market. To buy the complete report on Artificial Intelligence (AI) Market in the Education Sector, click here.Below, are other reports you might be interested with:Artificial Intelligence (AI) Market in the Education Sector in Healthcare Sector: Artificial intelligence (AI) in healthcare market size is estimated to grow at a CAGR of 23.5% between 2022 and 2027. The market size is forecast to increase by USD 11,827.99 million. This report covers clinical mass market segmentation by application (medical imaging and diagnostics, drug discovery, virtual assistants, operations management, and others), component (software, hardware, and services), and geography (North America, Europe, APAC, South America, and Middle East and Africa).Artificial Intelligence (AI) in Social Media Market: Artificial intelligence (AI) in social media market share is expected to increase by USD 3.66 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 26.93%. The report covers artificial intelligence (AI) in social media market segmentations by application (predictive risk management, consumer experience management, and sales and marketing) and geography (North America, Europe, APAC, South America, and Middle East and Africa).About Technavio:Technavio is a trusted source for industry news and insights that help businesses stay ahead in today's competitive landscape. With a team of experienced analysts and researchers, we continuously scrutinize and evaluate the dynamic landscape of markets across the globe. Our comprehensive coverage, meticulous research methodologies, and pragmatic industry expertise have earned us the trust and reliance of a vast clientele, including over 100 esteemed Fortune 500 organizations.SOURCE Technavio"
"https://www.prnewswire.com/news-releases/kaleyra-announces-changes-in-management-team-301899040.html","11 Aug, 2023, 16:15 ET","
News provided by

Kaleyra US



11 Aug, 2023, 16:15 ET
","Kaleyra Announces Changes in Management Team","Aug 11, 2023, 16:15 ETKaleyra Announces Changes in Management Teamglobal group providing mobile communication services to financial institutions, e-commerce players, OTTs, software companies, logistic enablers, healthcare providers, retailers, and other large organizations worldwide. Through its proprietary platform and robust APIs, Kaleyra manages multi-channel integratedMore news about: Kaleyra US","Kaleyra US","Kaleyra announces changes in the management team: Nicola Junior Vitto departure and new appointment of Mauro CarobeneNEW YORK, Aug. 11, 2023 /PRNewswire/ -- Kaleyra, Inc. (NYSE: KLR) (NYSE American: KLR WS) (""Kaleyra"" or the ""Company""), an enterprise Communication Platform as a Service (CPaaS), announces certain management changes. As previously disclosed, on June 28, 2023, the Company entered into an Agreement and Plan of Merger (the ""Merger Agreement"") with Tata Communications Limited, a company listed on BSE Limited and National Stock Exchange of India Limited (""Tata Communications""), pursuant to which, at the closing, upon the terms and subject to the conditions set forth therein, a wholly owned subsidiary of Tata Communications will merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Tata Communications. Nicola Vitto has announced his resignation from his position as Chief Product & Technology Officer of Kaleyra, Inc. (the ""Company""), with such resignation to become effective on September 4, 2023.In connection with the execution of the Merger Agreement, the Company has ceased its search for a new Chief Executive Officer. It is contemplated that Dario Calogero will continue to serve as Chief Executive Officer of the Company up to the closing of the Merger and Mauro Carobene, the Company's Chief Business Officer has recently entered into an agreement to become the Head of the Kaleyra Business.Dario Calogero, CEO of the Company, commented: ""I want to thank Nicola for his service with Kaleyra throughout these years for the outstanding work in building our platforms and services across our regions and I wish him all the best for his future endeavors. At the same time, I want to personally congratulate Mauro for the nomination as Head of the Kaleyra Business.""About KaleyraKaleyra, Inc. (NYSE: KLR) (NYSE American: KLR WS) is a global group providing mobile communication services to financial institutions, e-commerce players, OTTs, software companies, logistic enablers, healthcare providers, retailers, and other large organizations worldwide. Through its proprietary platform and robust APIs, Kaleyra manages multi-channel integrated communication services, consisting of messaging, rich messaging and instant messaging, video, push notifications, e-mail, voice services, and chatbots. Kaleyra's technology makes it possible to safely and securely manage billions of messages monthly with over 1,600 operator connections in 190+ countries, including all tier-1 US carriers. For more information, please visit www.kaleyra.com.Marketing Contacts Zephrin LaskerSenior Vice President, Marketing & Strategic Alliances [email protected]Lori PerkinsSenior Director <U+2013> Marketing and Communications[email protected]Investor ContactShannon Devine / Mark SchwalenbergMZ North America+1 203-741-8811[email protected]Statement Regarding Forward-Looking InformationThis Current Report on Form 8-K contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, its omnichannel and other product and global customer developments, and its expectations, beliefs, intentions, plans, prospects or strategies regarding the business plans of Kaleyra's management team. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words ""anticipate,"" ""believe,"" ""continue,"" ""could,"" ""estimate,"" ""expect,"" ""intends,"" ""may,"" ""might,"" ""plan,"" ""possible,"" ""potential,"" ""predict,"" ""project,"" ""should,"" ""would"" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements referenced or contained on this Form 8-K are based on certain assumptions and analyses made by Kaleyra in light of its experience and perception of historical trends, current conditions and expected future developments and their potential effects on Kaleyra as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting Kaleyra will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including Kaleyra's ability to regain compliance with the NYSE Listing Company Manual, the mix of services utilized by Kaleyra's customers and such customers' needs for these services, including any variability by geography, market acceptance of new service offerings, the ability of Kaleyra to expand what it does for existing customers as well as to add new customers, that Kaleyra will have sufficient capital to operate as anticipated, and the impact of other geopolitical and macroeconomic factors such as the war in Ukraine, may have on Kaleyra's operations, the demand for Kaleyra's products, global supply chains and economic activity in general. Additional risk factors that that may cause such a difference include, but are not limited to: (i) the ability of the parties to consummate the proposed transaction in a timely manner or at all; (ii) the satisfaction (or waiver) of closing conditions to the consummation of the proposed transaction; (iii) potential delays in consummation the proposed transaction; (iv) the ability of Kaleyra and Tata Communications to timely and successfully achieve the anticipated benefits of the proposed transaction; (v) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement; (vi) significant transaction costs associated with the proposed transaction; (vii) potential litigation relating to the proposed transaction; (viii) the risk that disruptions from the proposed transaction will harm Kaleyra's business, including current plans and operations; (ix) the ability of Kaleyra to retain and hire key personnel; (x) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction; (xi) legislative, regulatory and economic developments affecting Kaleyra's business; (xii) general economic and market developments and conditions; (xiii) the evolving legal, regulatory and tax regimes under which Kaleyra operates; and (xiv) potential business uncertainty, including changes to existing business relationships, during the pendency of the merger that could affect Kaleyra's financial performance. Therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. The Company refers you to the ""Risk Factors"" and ""Management's Discussion and Analysis of Financial Condition and Results of Operations"" sections of the Company's Form 10-K for the fiscal year ended December 31, 2022, and comparable sections of the Company's Quarterly Reports on Form 10-Q and other filings, which have been filed with the SEC and are available on the SEC's website at www.sec.gov. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.SOURCE Kaleyra US"
"https://www.prnewswire.com/news-releases/ira-capital-launches-flagship-500-million-healthcare-real-estate-fund-301899253.html","12 Aug, 2023, 15:27 ET","
News provided by

IRA Capital



12 Aug, 2023, 15:27 ET
","IRA Capital Launches Flagship $500 Million Healthcare Real Estate Fund","Aug 12, 2023, 15:27 ETIRA Capital Launches Flagship $500 Million Healthcare Real Estate FundIRA will be leveraging its compelling track record in healthcare real estate, which has averaged a net 48% annualized return and a net 1.7x equity multiple to its investors. IRA has been among the most active healthcare real estate investors in the United States. The firm has demonstratedMore news about: IRA Capital","IRA Capital","IRVINE, Calif., Aug, 12, 2023 /PRNewswire/ -- IRA Capital (""IRA""), a leading Southern-California based private equity firm, has announced the launch of IRA Healthcare Real Estate Fund, L.P. (the ""Fund"") <U+2013> a $500 Million closed-end fund focused on the acquisition of medical properties and senior housing assets across the United States. IRA will be leveraging its compelling track record in healthcare real estate, which has averaged a net 48% annualized return and a net 1.7x equity multiple to its investors. IRA has been among the most active healthcare real estate investors in the United States. The firm has demonstrated its ability to execute at scale over the past 13 years, having exited numerous investments to some of the largest institutions and public REITS. IRA sold a 19-property portfolio for approximately $300 Million to Welltower REIT in January 2020 and another 29-property portfolio for approximately $620 Million to Nuveen Real Estate in August 2021.Having built one of the most reputable privately held healthcare real estate platforms in the country, IRA has established extensive relationships with health systems and medical providers. The firm has successfully utilized its relationships to source attractive opportunities and aggregate best-in-class assets. ""Our firm's expertise and exceptional track record in this niche asset class combined with strong secular trends uniquely positions us to deliver strong risk-adjusted returns for the Fund"" says Amer Kasm, co-founder at IRA Capital. The Fund will focus on the acquisition, development, and financing of well-located healthcare assets in high barrier-to-entry and supply-constrained markets. IRA's principals will be co-investing alongside existing and new investors. The offering will be open to domestic and foreign endowments, pension funds, insurance companies, family offices, fund of funds, registered investment advisors, and other qualified high net-worth investors. Investors will have the opportunity to diversify capital across healthcare assets and geographic markets, with projected annualized net returns of 14%-16% and a net equity multiple of 1.7x-1.9x. According to IRA Capital co-founder Jay Gangwal, ""We intend to acquire assets across the risk spectrum with a focus on core-plus and value-add opportunities. The diverse strategy will result in a balanced portfolio with a combination of yield and appreciation, while providing downside protection given the needs-based demand. The current capital markets environment is also presenting unique re-positioning opportunities that we expect will create significant value and generate outsized returns.""Sidley Austin LLP served as legal counsel in the Fund's formation.About IRA CapitalIRA Capital is a Southern-California based private equity firm founded in 2010 by partners Amer Kasm, Samir Patel, Jay Gangwal, Amer Malas, and Mohannad Malas. IRA invests capital for its own account and on behalf of its co-investment partners, which include pension funds, institutions, and family offices. Headquartered in Irvine California, IRA has acquired over seven million square feet of property in 30 states, with a total capitalization greater than $3 Billion. www.IRAcapital.comFor more information, please contact:Danielle BallCorporate Communications[email protected] / +1.949.258.7411SOURCE IRA Capital"
"https://www.prnewswire.com/news-releases/new-office-expansion-enables-ira-capital-to-accelerate-growth-301899136.html","11 Aug, 2023, 21:52 ET","
News provided by

IRA Capital



11 Aug, 2023, 21:52 ET
","New office expansion enables IRA Capital to accelerate growth","Aug 11, 2023, 21:52 ETNew office expansion enables IRA Capital to accelerate growthpartners and the local business community.Considering IRA's focus in the healthcare real estate markets, IRA will be hosting a private event at its offices next month to provide insights on the local and healthcare markets. Guest speakers will include Farrah Khan,More news about: IRA Capital","IRA Capital","IRVINE, Calif., Aug. 11, 2023 /PRNewswire/ -- IRA Capital (""IRA""), a leading private equity firm, has announced the recent relocation of its offices in Irvine to accommodate the company's continued growth. IRA relocated to a newly constructed contemporary office totaling approximately 15,000 SF at 3121 Michelson Drive in Park Place-Irvine from its previous location of 6,000 SF at the Irvine Concourse. IRA's new office marks another milestone for the company as it continues to grow and enhance its capabilities at a pivotal juncture in the capital markets.IRA's office is strategically located minutes from Orange County's John Wayne Airport and Newport Beach's Fashion Island. The new office is also caddy-corner to the 150,000 SF, 9-acre project (at Michelson and Jamboree) that IRA acquired in 2021. Also, one mile from the new office is the 25-acre parcel known as Von Karman Creative Campus, which IRA acquired earlier this year. Given IRA's substantial local investment in Irvine and the potential redevelopment of these projects, the company wanted to invest in a special place not only for its employees, but also as a gathering hub for its partners and the local business community.Considering IRA's focus in the healthcare real estate markets, IRA will be hosting a private event at its offices next month to provide insights on the local and healthcare markets. Guest speakers will include Farrah Khan, the Mayor of the City of Irvine, who will be shedding additional light on the current development environment and discussing opportunities for growth and innovation. Also speaking will be Chad Lefteris, the CEO of UCI Health, which is in the process of constructing a $1.3 Billion, 144-bed hospital/medical complex just down the street from IRA's offices.""We are excited to announce the opening of our new office in Irvine, CA,"" said Mohannad Malas, IRA Capital Co-Founder, Managing Partner. ""This expansion is a reflection of our dedication to delivering exceptional investment opportunities and value to our stakeholders. The continued growth deepens IRA's relationships, fosters collaboration, promotes innovation, and better serves the unique needs of the community.""IRA's new office space also comes at a time when the company recently announced the launch of its flagship $500 Million healthcare real estate fund, which will be targeting medical properties and senior housing assets across the United States.About IRA Capital IRA Capital is a Southern-California based private equity firm founded in 2010 by partners Amer Kasm, Samir Patel, Jay Gangwal, Amer Malas, and Mohannad Malas. IRA invests capital for its own account and on behalf of its co-investment partners, which include pension funds, institutions, and family offices. Headquartered in Irvine California, IRA has acquired over seven million square feet of property in 30 states, with a total capitalization greater than $3 Billion. For more information, please visit www.IRAcapital.com.For more information, please contact: Danielle Ball, IRA Capital Corporate Communications/ 949.258.7411SOURCE IRA Capital"
"https://www.prnewswire.com/news-releases/global-disposable-face-masks-markets-2023-2030---rapid-industrialization-and-health-awareness-spurs-demand-301898823.html","11 Aug, 2023, 21:45 ET","
News provided by

Research and Markets



11 Aug, 2023, 21:45 ET
","Global Disposable Face Masks Markets, 2023-2030 - Rapid Industrialization and Health Awareness Spurs Demand","Aug 11, 2023, 21:45 ETGlobal Disposable Face Masks Markets, 2023-2030 - Rapid Industrialization and Health Awareness Spurs Demandregulations regarding worker safety, particularly in the healthcare industryGrowth of the Asia Pacific segment is backed by increased awareness regarding health and personal hygiene, along with rising spending on healthcare facilitiesProduct innovations, alongMore news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Disposable Face Masks Market Size, Share & Trends Analysis Report By Product (Protective Masks, Dust Masks, Non-woven Masks), By Application (Industrial, Personal), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030"" report has been added to ResearchAndMarkets.com's offering.The global disposable face masks market size is expected to reach USD 2.99 billion by 2030 and is expected to grow at a CAGR of 1.9% from 2023 to 2030The COVID-19 pandemic, rapid industrialization, rising pollution levels, and growing awareness among users regarding health protection are the factors expected to propel the need for disposable face protectors over the projected period. Asia Pacific is expected to remain one of the prominent regional markets owing to the growing industrial sector in emerging economies including China and India. Furthermore, supportive government initiatives to protect the health of the working and non-working classes in the above-mentioned countries are driving the product demand in the near future.Moreover, the increase in air pollution, fast-paced growth of the healthcare industry, large consumer base, increasing consumer consciousness, and the growing presence of a number of disposable face mask manufacturers in the region are driving the growth of the market in the region. Furthermore, the implementation of various safety norms for workers' safety in developed economies including the U.S. and Germany is expected to remain a key trend in the market.The industry is highly competitive in terms of product variation and pricing. Key players are focusing on inventing disposable masks that will enable users with better ventilation, filtration, water-proof, and other benefits. Rising consumer demand for innovative, high filtration efficiency, and application-specific masks is expected to open new opportunities for the key players over the next few years.The introduction of special respiratory disposable masks is a key trend in the market, enabling manufacturers to customize the products accordingly to meet customer specifications.Disposable Face Masks Market Report HighlightsThe protective mask segment is expected to expand at a significant pace from 2023 to 2030 owing to rapid industrialization and increasing initiatives to protect health on a global levelThe industrial application segment is expected to garner a huge market share owing to stringent regulations regarding worker safety, particularly in the healthcare industryGrowth of the Asia Pacific segment is backed by increased awareness regarding health and personal hygiene, along with rising spending on healthcare facilitiesProduct innovations, along with the establishment of strategic business partnerships with the distributors, are expected to remain favorable factors for market growth over the next few yearsKey Topics Covered:Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segmental Outlook2.3. Competitive InsightsChapter 3. Disposable Face Masks Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Industry Value Chain Analysis3.2.1. Sales/Retail Channel Analysis3.2.2. Profit Margin Analysis3.3. Market Dynamics3.4. Industry Analysis - Porter's3.5. Market Entry StrategiesChapter 4. Consumer Behavior Analysis4.1. Consumer Trends and Preferences4.2. Factors Affecting Buying Decision4.3. Consumer Product Adoption4.4. Observations & RecommendationsChapter 5. Disposable Face Masks Market: Product Estimates & Trend Analysis5.1. Product Movement Analysis & Market Share, 2022 & 20305.2. Protective masks5.3. Dust masks5.4. Non-woven masksChapter 6. Disposable Face Masks Market: Application Estimates & Trend Analysis6.1. Application Movement Analysis & Market Share, 2022 & 20306.2. Industrial6.3. PersonalChapter 7. Disposable Face Masks Market: Distribution Channel Estimates & Trend Analysis7.1. Distribution Channel Movement Analysis & Market Share, 2022 & 20307.2. Online7.3. OfflineChapter 8. Disposable Face Masks Market: Regional Estimates & Trend Analysis8.1. Regional Movement Analysis & Market Share, 2022 & 2030Chapter 9. Competitive Analysis9.1. Key global players, recent developments & their impact on the industry9.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)9.3. Vendor Landscape9.3.1. Key company market share analysis, 2022Chapter 10. Company ProfilesHoneywell International Inc.3MMoldex-Metric, Inc.Kimberly-Clark CorporationUvex groupKowa American CorporationSAS Safety Corp.The Gerson Companies, Inc.DACHJIANGSU TEYIN IMP. & EXP. CO., LTD.For more information about this report visit https://www.researchandmarkets.com/r/d9nculAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected]For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/global-oxygen-concentrators-industry-report-2023-a-5-1-billion-market-by-2030---iot-integration-and-rising-preference-for-home-based-oxygen-therapy-to-propel-growth-301898816.html","11 Aug, 2023, 21:30 ET","
News provided by

Research and Markets



11 Aug, 2023, 21:30 ET
","Global Oxygen Concentrators Industry Report 2023: A $5.1 Billion Market by 2030 - IoT Integration and Rising Preference for Home-Based Oxygen Therapy to Propel Growth","Aug 11, 2023, 21:30 ETGlobal Oxygen Concentrators Industry Report 2023: A $5.1 Billion Market by 2030 - IoT Integration and Rising Preference for Home-Based Oxygen Therapy to Propel GrowthKoninklijke Philips N.V.)Invacare CorporationCaire Medical (A Subsidiary Of Ngk Spark Plug)Devilbiss Healthcare (A Subsidiary Of Drive Medical)GCE HealthcareNidek Medical Products, IncKrober Medizintechnik GmbhBesco MedicalCanta MedicalContecMore news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Oxygen Concentrators Market Size, Share & Trends Analysis Report By Product Type (Portable, Fixed), By Application (Home Care, Non-homecare), By Technology, By Region, And Segment Forecasts, 2023 - 2030"" report has been added to ResearchAndMarkets.com's offering.The global oxygen concentrators market size is expected to reach USD 5.1 billion by 2030The landscape of the oxygen concentrator market is undergoing a significant transformation driven by various factors that are shaping its trajectory. The prevalence of respiratory diseases is on the rise, underscoring the urgent need for effective solutions. Simultaneously, the industry is witnessing a wave of innovation with the introduction of advanced product offerings.This drive for progress is evident in initiatives like O2 Concepts' launch of the Oxlife Liberty in October 2022, which is set to revolutionize the oxygen therapy landscape. Such endeavors highlight the industry's dedication to pushing boundaries and improving patient care.Alongside these advancements, the market is experiencing a shift in preferences, with an increasing number of individuals opting for home-based oxygen therapy. This preference for convenience and comfort is expected to fuel market growth consistently over the forecast period.Furthermore, the supportive hand of government initiatives and funding in healthcare infrastructure development is poised to amplify the demand for technologically advanced and cost-efficient oxygen concentrator devices. Notably, the integration of Internet of Things (IoT) technology into oxygen concentrators is further reshaping the medical device landscape, offering an array of benefits that outshine traditional methods.As the confluence of innovation, changing preferences, and supportive policies continues to drive the market, the future holds promising prospects for oxygen concentrator manufacturers and patients alike.By allowing for remote monitoring and management, IoT-enabled oxygen concentrators enable healthcare providers to monitor patients' oxygen levels in real-time and adjust the flow rate, leading to improved patient outcomes. This is expected to impel the market growth over a forecast period.Furthermore, prominent players in the industry, including Inogen, Inc.; Respironics (a subsidiary of Koninklijke Philips N.V.); and Caire Medical (a subsidiary of NGK Spark Plug) are employing various strategies such as acquisitions, collaborations, expansions, and new product launches to extend the availability and geographical reach of their product offerings.For instance, in February 2023, React Health, a specialist in medical device development, manufacturing, and distribution, successfully acquired Invacare's Respiratory line. This strategic acquisition enhances React Health's market position, expands its product portfolio, and enables it to serve a wider range of customers.Some of the prominent market players are Inogen, Inc.; Respironics (a subsidiary of Koninklijke Philips N.V.); Invacare Corporation; Caire Medical (a subsidiary of NGK Spark Plug); DeVilbiss Healthcare (a subsidiary of Drive Medical); Invacare Corporation; and Nidek Medical Products, Inc.Oxygen Concentrators Market Report HighlightsBased on product, the fixed medical oxygen concentrators segment accounted for the largest revenue share of 53.8% in 2022, owing to its increasing demand among patients suffering from breathing problemsBased on application, the home care segment dominated the industry with a revenue share of 60.2% in 2022, owing to the increasing adoption of Long-Term Oxygen Therapy (LTOT) devices in home settingsBased on technology, the continuous flow segment held the largest revenue share of 56.7% in 2022. This is attributed to the growing prevalence of long-term respiratory disorders such as asthma, COPD, bronchiectasis, and chronic sinusitisNorth America dominated the global market with a share of 38.2% in 2022, owing to the presence of advanced healthcare infrastructure, high investment in R&D, availability of the latest technologies, and product launchesKey Attributes:Report Attribute Details No. of Pages 298 Forecast Period 2022 - 2030 Estimated Market Value (USD) in 2022 $3.4 billion Forecasted Market Value (USD) by 2030 $5.1 billion Compound Annual Growth Rate 5.2 % Regions Covered Global Oxygen Concentrators Market DynamicsDriversRising Prevalence Of Respiratory DiseasesLaunch Of New Generation Products And Increasing Business ExpansionRise In Demand For Portable And Homecare Oxygen ConcentratorsGrowing Preference For Home-Based Oxygen TherapyRestraintsHigh Cost Associated With Oxygen ConcentratorsBusiness AnalysisOxygen Concentrators Market Analysis Tools: Porter'sPestel AnalysisCompetitive Landscape AnalysisCompany/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)Company Market Position And Share AnalysisEstimated Global Company Market Share Analysis, 2022Estimated U.S. Specific Company Market Share Analysis, 2022Company ProfilesInogen, Inc.Respironics (A Subsidiary Of Koninklijke Philips N.V.)Invacare CorporationCaire Medical (A Subsidiary Of Ngk Spark Plug)Devilbiss Healthcare (A Subsidiary Of Drive Medical)GCE HealthcareNidek Medical Products, IncKrober Medizintechnik GmbhBesco MedicalCanta MedicalContec MedicalScaleo MedicalFor more information about this report visit https://www.researchandmarkets.com/r/5axfdmAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected]For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/global-artificial-intelligence-in-cancer-diagnostics-research-report-2023-2030-market-to-grow-by-over-850-million---increasing-number-of-startups--collaborations-and-growing-vc-funding-301898808.html","11 Aug, 2023, 20:15 ET","
News provided by

Research and Markets



11 Aug, 2023, 20:15 ET
","Global Artificial Intelligence In Cancer Diagnostics Research Report 2023-2030: Market to Grow by Over $850 Million - Increasing Number of Startups & Collaborations and Growing VC Funding","Aug 11, 2023, 20:15 ETGlobal Artificial Intelligence In Cancer Diagnostics Research Report 2023-2030: Market to Grow by Over $850 Million - Increasing Number of Startups & Collaborations and Growing VC Fundingartificial intelligence (AI) in cancer diagnostics is poised for remarkable expansion. The imperative to curtail healthcare costs, coupled with the escalating significance of big data within the healthcare domain, sets the stage for this advancement.The burgeoning adoption of precision medicine, complementedMore news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Artificial Intelligence In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component, By Cancer Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030"" report has been added to ResearchAndMarkets.com's offering.The global AI in cancer diagnostics market size is expected to reach USD 996.1 million by 2030, growing at 26.3%Driven by a convergence of pivotal factors, the growth trajectory of artificial intelligence (AI) in cancer diagnostics is poised for remarkable expansion. The imperative to curtail healthcare costs, coupled with the escalating significance of big data within the healthcare domain, sets the stage for this advancement.The burgeoning adoption of precision medicine, complemented by the diminishing hardware expenses, adds further impetus to the growth. The burgeoning landscape witnesses AI's multifaceted applications across healthcare sectors, particularly in diagnostics.This amplification aligns with the mounting cancer prevalence and the simultaneous shortfall in public health workforce. In tandem with these drivers, AI's transformative role in cancer care escalates, reinforced by robust venture capital investments that continue to fuel the burgeoning demand for this groundbreaking technology.The presence of prominent players in the market such as Microsoft, Flatiron, Therapixel, and Tempus, is anticipated to positively impact the growth.These players are adopting strategies such as acquisitions, collaborations, expansions, and new product launches to increase the reach of their products in the industry and increase the availability of their products & services in diverse geographical areas.For instance, in December 2021, Microsoft announced a partnership with CVS Health to develop innovative solutions for patients to improve their health while empowering healthcare professionals with tools to better service patients.Furthermore, the rising government support in the form of funding and initiatives for the development of healthcare infrastructure is anticipated to drive the demand for technologically advanced and cost-efficient devices over the forecast period.AI In Cancer Diagnostics Market Report HighlightsBased on component, the software solutions segment held the largest market share of 43.7% in 2022. The development of AI-based software solutions for cancer diagnostics is one of the key factors boosting segment growthBased on cancer type, the other cancers segment emerged as the largest segment with a revenue share of 33.6% in 2022. Growing adoption of a sedentary lifestyle increased alcohol & tobacco consumption, and physical inactivity are driving the incidence of cancers such as bladder and skin cancersBased on end-user, the hospital segment emerged as the largest end-user in the market, with a market share of 57.7% in 2022. The growing shortage of medical professionals and technological advancements in hospitals is expected to drive the segmentNorth America dominated the global market with a share of 56.0% in 2022. The rising adoption of healthcare IT solutions, the well-established healthcare sector, and the availability of funding for developing AI capabilities are some of the factors contributing to the growth of the market in the regionCompany ProfilesEarlySignCancer Center.aiMicrosoftFlatironPath AITherapixelTempusPaige AI Inc.Kheiron Medical Technologies Limited OverviewSkinVisionKey Attributes:Report Attribute Details No. of Pages 90 Forecast Period 2022 - 2030 Estimated Market Value (USD) in 2022 $137.8 million Forecasted Market Value (USD) by 2030 $996.1 million Compound Annual Growth Rate 26.3 % Regions Covered Global Key Topics Covered: Chapter 1 Methodology And ScopeChapter 2 Executive Summary2.1 Market Outlook2.2 Segment Outlook2.3 Regional Insight2.4 Competitive Insights2.5 Artificial Intelligence (Ai) In Cancer Diagnostics Market Snapshot2.6 Artificial Intelligence (Ai) In Cancer Diagnostics Segment Snapshot2.7 Artificial Intelligence (Ai) In Cancer Diagnostics Competitive SnapshotChapter 3 Artificial Intelligence (Ai) In Cancer Diagnostics Market Variables, Trends & Scope3.1 Market Lineage Outlook3.1.1 Parent Market Outlook3.1.1.1 Ai In Healthcare Market3.1.2 Related/Ancillary Market Outlook3.1.2.1 Artificial Intelligence In Medical Imaging Market3.2 Penetration And Growth Prospect Mapping3.3 User Perspective Analysis3.3.1 Consumer Behavior Analysis3.3.2 Market Influencer Analysis3.4 Artificial Intelligence (Ai) In Cancer Diagnostics Market Dynamics3.4.1 Market Driver Analysis3.4.1.1 Early Detection And Classification Of Diseases3.4.1.2 Early Detection And Classification Of Cancer3.4.1.3 Increasing Use Of Ai In Chronic Disease Management3.4.1.4 Increasing Number Of Startups & Collaborations And Growing Venture Capitalist Funding3.4.2 Market Restraint Analysis3.4.2.1 Highly Regulated Industry3.4.2.2 Procurement Costs And Maintenance3.5 Artificial Intelligence In Cancer Diagnostics Market Analysis Tools3.5.1 Industry Analysis - Porter's3.5.2 Pestel Analysis3.6 Impact Of The Covid-19 Pandemic On Ai In Cancer Diagnostics MarketChapter 4 Global Artificial Intelligence (Ai) In Diagnostics Market: Competitive Analysis4.1 Company/Competition Categorization (Key Innovators, Market Leaders, & Emerging Players)4.2 Recent Developments, By Key Market Participants4.3 Company Market Position AnalysisChapter 5 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Estimates & Trend Analysis5.1 Segment Dashboard5.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Analysis, 2022 & 2030 (USD Million) 5.3 Ai In Cancer Diagnostics Market, By Component, 2017 - 2030 (USD Million)5.4 Software Solutions5.5 Hardware5.6 ServicesChapter 6 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis6.1 Segment Dashboard6.2 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Analysis, USD Million, 2022 & 20306.3 AI In Cancer Diagnostics Market, By Cancer Type, 2017 - 2030 (USD Million)6.4 Breast Cancer6.5 Lung Cancer6.6 Prostate Cancer6.7 Colorectal Cancer6.8 Brain TumorChapter 7 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Estimates & Trend Analysis7.1 Segment Dashboard7.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Analysis, USD Million, 2022 & 20307.3 Ai In Cancer Diagnostics Market, By End-User, 2017 - 2030 (USD Million)7.4 Hospitals7.5 Surgical Centers And Medical InstitutesChapter 8 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Regional Estimates & Trend Analysis: By Component, Cancer Type, And End-User8.1 Regional Market Key Takeaways8.2 Regional Market Snapshot8.3 Growing Global Cancer PrevalenceChapter 9 Competitive Landscape9.1. Recent Developments & Impact Analysis, By Key Market Participants9.2. Competition Categorization9.3. Company Market Position AnalysisFor more information about this report visit https://www.researchandmarkets.com/r/xvxhhwAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected] For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo : https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/global-retail-health-market-report-2023-expansive-growth-opportunities---from-in-store-clinics-to-clinical-trials-wellness-and-womens-health-301898776.html","11 Aug, 2023, 20:00 ET","
News provided by

Research and Markets



11 Aug, 2023, 20:00 ET
","Global Retail Health Market Report 2023: Expansive Growth Opportunities - From In-store Clinics to Clinical Trials, Wellness, and Women's Health","Aug 11, 2023, 20:00 ETGlobal Retail Health Market Report 2023: Expansive Growth Opportunities - From In-store Clinics to Clinical Trials, Wellness, and Women's Healthfusion of healthcare and wellness offerings emanating from retail giants, drugstores, and discount retailers.In an evolving healthcare landscape, the concept of retail health has emerged as a transformative paradigm, bridging the gap between consumer-centric services and traditional healthcare provisions.More news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Transformation of Retail Health: Analysis of Trends and Their Impact on Traditional Healthcare Providers"" report has been added to ResearchAndMarkets.com's offering.This study sets out to delineate the contours of this dynamic phenomenon, defining retail health as the fusion of healthcare and wellness offerings emanating from retail giants, drugstores, and discount retailers.In an evolving healthcare landscape, the concept of retail health has emerged as a transformative paradigm, bridging the gap between consumer-centric services and traditional healthcare provisions.Beyond the confines of conventional pharmacy services, this report delves into a comprehensive overview of the US retail health market, dissecting its multifaceted impact on the established realm of healthcare providers.A central focus lies in the role played by retail health providers in filling the void left by traditional healthcare avenues, offering an array of services that span from urgent care to chronic condition management, from preventive measures to the blossoming landscape of women's health, thus redefining the scope of accessible and consumer-oriented healthcare.High cost is a barrier to healthcare and medication access, affecting uninsured and aged populations the most. People often skip their medication refills, follow-up visits, and treatment cycles, failing to afford the cost. A significant proportion of the population is in debt due to healthcare bills.Despite such high costs, healthcare services have not been up to standard, and a majority of the population is dissatisfied with the traditional system. Patients from rural and remote locations struggle to access primary care. Numerous challenges related to cost and convenience lead patients to switch to retail health systems.A selection of companies mentioned in this report includesAmazonAetna Health (part of CVS Health)CVS HealthKaiser PermanenteKrogerOak Street Health (part of CVS Health)One MedicalVillageMD (associated with Walgreens)WalgreensWalmart Health CenterKey Topics Covered:1. Strategic ImperativesWhy is it Increasingly Difficult to Grow?The Strategic Imperative The Impact of the Top 3 Strategic Imperatives on the Retail Health Industry and Traditional HealthcareGrowth Opportunities Fuel the Growth Pipeline Engine2. Growth Opportunity AnalysisScope of AnalysisMarket SegmentationGetting the Definition RightRetail Care ModelsTypes of Retail Health OfferingsRetail Health's Expanded Healthcare Role in the Continuum of CareGaps in Traditional Healthcare - Key Drivers for Retail HealthRetail Health Drivers and RestraintsGrowing Consumer Preference for Retail PharmaciesPatient Care Journey - Traditional Compared to Retail HealthOpportunity for Retail HealthCompetitive LandscapeCVS Health - The Minute Clinic (Retail Health)CVS Health - Oak Street Health (Primary Care)CVS Health - Aetna Health (Payer)Kroger - The Little ClinicWalgreens - VillageMDKaiser Permanente Target ClinicWalmart Health CenterAmazon - One MedicalOther Key VendorsTechnology Enabling VendorsKey Value Propositions by RetailersRetail Health Impact on Healthcare SystemsImperatives for Traditional Healthcare Providers3. Growth Opportunity UniverseIn-store Health ClinicsCo-located and Outside-store Health ClinicsBehavioral/Mental Health and WellnessClinical Trials and RWE ServicesWomen's HealthFor more information about this report visit https://www.researchandmarkets.com/r/liz1odAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected] For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/new-iehp-health-career-academy-to-address-critical-health-care-needs-301899128.html","11 Aug, 2023, 19:59 ET","
News provided by

Inland Empire Health Plan (IEHP)



11 Aug, 2023, 19:59 ET
","New IEHP Health Career Academy to address critical health care needs","Aug 11, 2023, 19:59 ETNew IEHP Health Career Academy to address critical health care needsproviding a more financially inclusive and accessible education,"" according to both entities. Participants can also receive entrepreneurial skills in the healthcare industry to support related start-up businesses, officials said.About IEHPWith a mission to heal and inspire the human spirit,More news about: Inland Empire Health Plan (IEHP)","Inland Empire Health Plan (IEHP)","RANCHO CUCAMONGA, Calif., Aug. 11, 2023 /PRNewswire/ -- To address the growing need for health care professionals in the region, Inland Empire Health Plan (IEHP) and University of La Verne are collaborating to create a brand-new resource: the IEHP Health Career Academy.Continue ReadingInland Empire Health Plan (IEHP) and University of La Verne are partnering to create a brand-new resource: the IEHP Health Career Academy. The academy's mission is to address the growing need for health care professionals in the region.The not-for-profit health plan has committed $1.5 million to launch the academy under the University of La Verne Randall Lewis Center for Entrepreneurship, Innovation and Social Impact <U+2014> a pillar of the university's emerging education and innovation corridor located off D Street, between North Sultana and North Plum avenues in Ontario.The academy's goal is to fill critical workforce needs and retain talent to address health disparities within one of the fastest-growing population regions in the country. Funding will support the creation of certification for three critical frontline career fields: nursing assistants, medical assistants and central service technicians. The first program cohorts are expected to launch late spring 2024.""This seed funding will support and enhance the great work University of La Verne is already doing to educate the next generation of frontline health care workers,"" said Jarrod McNaughton, IEHP's chief executive officer. ""The new IEHP Health Career Academy will help to bolster the emerging workforce for the future of health care in the Inland Empire.""The academy complements and aligns with the vision for the corridor, which will include programs that focus on entrepreneurship, law, public service, health equity, community well-being and educational advancement in historically underserved communities, according to the university.""The new IEHP Health Career Academy will help address the critical shortage of frontline health care workers and accelerate professional training and certification in new and emerging subdisciplines requiring technological and interdisciplinary expertise in addressing patient and community challenges,"" said University of La Verne President Devorah Lieberman.One highlight of the new academy will be the Earn-to-Learn program, which provides students the opportunity to pursue necessary field certification while working in related entry-level positions and earning experience and pay. This model is a ""practical way of alleviating a burden by providing a more financially inclusive and accessible education,"" according to both entities. Participants can also receive entrepreneurial skills in the healthcare industry to support related start-up businesses, officials said.About IEHPWith a mission to heal and inspire the human spirit, Inland Empire Health Plan (IEHP) is one of the top 10 largest Medicaid health plans, the largest not-for-profit Medicare-Medicaid plan in the country and for the third year in a row, certified as A Great Place To Work<U+00AE>. In its 27th year, IEHP supports more than 1.6 million Riverside and San Bernardino County residents enrolled in Medicaid or IEHP DualChoice (those with both Medi-Cal and Medicare). Today, IEHP has a growing network of 7,000 providers and 3,000 team members who are fully committed to the vision: We will not rest until our communities enjoy optimal care and vibrant health. To learn more, visit iehp.org.About University of LaVerneThe University of La Verne is a nonprofit comprehensive institution offering a wide-range of liberal arts and professional programs incorporating the same core values it was founded on in 1891 - lifelong learning, ethical reasoning, civic and community engagement, and diversity and inclusivity. With more than 70 percent of students from underrepresented groups, the federally designated Hispanic-Serving Institution is among the most diverse small private universities in the nation. The Southern California-based university has five colleges and offers classes at the historic La Verne campus, through regional campuses, and online. The University of La Verne is nationally recognized and consistently holds rankings on the U.S. News & World Report National University, Best Value Schools, Top Performers on Social Mobility, and Best Online Programs lists.SOURCE Inland Empire Health Plan (IEHP)"
"https://www.prnewswire.com/news-releases/global-dental-chair-market-analysis-report-2023-market-is-forecast-to-grow-over-520-000-by-2030-with-north-america-claiming-the-highest-share-301898770.html","11 Aug, 2023, 19:45 ET","
News provided by

Research and Markets



11 Aug, 2023, 19:45 ET
","Global Dental Chair Market Analysis Report 2023: Market is Forecast to Grow Over $520,000 by 2030 with North America Claiming the Highest Share","Aug 11, 2023, 19:45 ETGlobal Dental Chair Market Analysis Report 2023: Market is Forecast to Grow Over $520,000 by 2030 with North America Claiming the Highest Sharescreens is making these chairs more comfortable than others. In addition, mobile independent chairs can help in increasing patients' access to oral healthcare facilities. Such innovations can further increase the adoption rate of dental chairs and boost market growth.The negative impactMore news about: Research and Markets","Research and Markets","DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The ""Dental Chair Market Size, Share & Trends Analysis Report By Product, By Type (Ceiling-Mounted Design, Dental-Chair Mounted Design), By Application (Examination, Surgery), By Region, And Segment Forecasts, 2023 - 2030"" report has been added to ResearchAndMarkets.com's offering.The global dental chair market size is expected to reach USD 1.48 billion by 2030, expanding at a CAGR of 5.7%The market growth can be attributed to the increasing awareness and prevalence of oral diseases and the consequent increase in the demand for dental care facilities. Development in infrastructure and improving access of low- and middle-income groups to dental facilities can further boost the market. According to the Global Oral Health Status Report 2022, published by the World Health Organization, approximately two billion people across the globe are suffering from caries of permanent teeth and 514 million children are suffering from caries of primary teeth.Moreover, one billion people worldwide are suffering from severe gum disease which is also a major cause of total tooth loss. The bad oral habits of people such as tobacco consumption and poor hygiene maintenance are contributing to the rising prevalence of these diseases.The technological advancements in the dental chair industry are also contributing to their growing demand. The addition of innovative features such as touch screens is making these chairs more comfortable than others. In addition, mobile independent chairs can help in increasing patients' access to oral healthcare facilities. Such innovations can further increase the adoption rate of dental chairs and boost market growth.The negative impact of the COVID-19 pandemic was also observed in this market. Several restrictions imposed by governments across countries limited people's movement and their visits to hospitals decreased significantly. However, the market witnessed a recovery as restrictions were eased.Dental Chair Market Report HighlightsBased on product, the power dental chair segment accounted for the largest revenue share of 63.1% in 2022 and it is also expected to register the fastest CAGR of 5.9% over the forecast period. This growth can be attributed to technological advancements and the increasing emphasis of dentists on providing their patients with maximum comfortBased on type, the ceiling-mounted segment accounted for the largest revenue share of 39.7% in 2022, owing to its easy-to-maintain attribute and effectivenessBased on application, the examination segment dominated the market with a share of 28.4% in 2022 owing to increasing awareness regarding oral hygieneIn 2022, North America dominated the market with a revenue share of 38.1%, owing to the use of advanced technology and increased consumer knowledge. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to the increasing prevalence of oral diseasesCompetitive LandscapeAustin Dental Equipment CompanyMidmarkCraftmaster Contour Equipment, Inc.Xo CARE A/SSironaHenry Schein, Inc.Danaher CorporationPLANMECA OYPatterson Dental Supply, Inc.StraumannKey Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Dental Chair Market Variables, Trends & Scope3.1. Market Lineage Outlook3.1.1. Parent market outlook3.1.2. Related/ancillary market outlook3.2. Penetration & Growth Prospect Mapping3.3. Industry Value Chain Analysis3.3.1. Reimbursement framework3.4. Market Dynamics3.4.1. Market driver analysis3.4.2. Market restraint analysis3.5. Dental Chair Market Analysis Tools3.5.1. Industry Analysis - Porter's3.5.2. PESTEL AnalysisChapter 4. Dental Chair: Product Estimates & Trend Analysis4.1. Dental Chair Market: Key Takeaways4.2. Dental Chair Market: Movement & Market Share Analysis, 2022 & 20304.3. Powered dental chair4.4. Non-powered dental chairChapter 5. Dental Chair: Type Estimates & Trend Analysis5.1. Dental Chair Market: Key Takeaways5.2. Dental Chair Market: Movement & Market Share Analysis, 2022 & 20305.3. Ceiling-mounted design5.4. Mobile-Independent Design5.5. Dental-chair mounted designChapter 6. Dental Chair: Application Estimates & Trend Analysis6.1. Dental Chair Market: Key Takeaways6.2. Dental Chair Market: Movement & Market Share Analysis, 2022 & 20306.3. Examination6.4. Surgery6.5. OrthodonticsChapter 7. Dental Chair Market: Regional Estimates & Trend Analysis7.1. Regional Outlook7.2. Dental Chair Market by Region: Key Marketplace TakeawayFor more information about this report visit https://www.researchandmarkets.com/r/k40fqmAbout ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected] For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgSOURCE Research and Markets"
"https://www.prnewswire.com/news-releases/global-synthetic-biology-market-to-grow-by-usd-28-253-12-million-between-2022-and-2027--the-growing-application-of-synthetic-biology-drives-the-market-301898157.html","11 Aug, 2023, 19:00 ET","
News provided by

Technavio



11 Aug, 2023, 19:00 ET
","Global Synthetic Biology Market to grow by USD 28,253.12 million between 2022 and 2027 | The growing application of synthetic biology drives the market","Aug 11, 2023, 19:00 ETGlobal Synthetic Biology Market to grow by USD 28,253.12 million between 2022 and 2027 | The growing application of synthetic biology drives the marketWorld (ROW)The report provides a comprehensive insight into the market segmentation by application (healthcare, industrial, food and agriculture, and others), product (oligonucleotides, enzymes, cloning technology kits, xeno-nucleic acids, and chassis organism),More news about: Technavio","Technavio","NEW YORK, Aug. 11, 2023 /PRNewswire/ -- Technavio, a leading provider of industry news and insights, is pleased to announce its latest report on the Global Synthetic Biology Market. The report highlights the estimated growth and forecast for the market between 2022 and 2027, predicting an increase in market size of USD 28,253.12 million and a rise at a CAGR of 25.6%.Continue ReadingTechnavio has announced its latest market research report titled Global Synthetic Biology MarketThe global mass spectrometry market is being propelled by several key drivers. Notably, the significant rise in research and development investments by pharmaceutical, biotechnology companies, and research institutes to tackle the increasing prevalence of chronic diseases worldwide is a major driving force. Mass spectrometry's pivotal role in offering unique insights into molecular interactions and protein functions is driving its adoption in drug development, contributing to a deeper understanding of diseases at the molecular level. Additionally, the market is benefiting from the trend toward portable mass spectrometers, enhancing their accessibility and applicability across various industries and applications.YoY growth 2022-2023(%) 25.35 % Key Countries North America, Europe, Asia, and Rest of World (ROW) The report provides a comprehensive insight into the market segmentation by application (healthcare, industrial, food and agriculture, and others), product (oligonucleotides, enzymes, cloning technology kits, xeno-nucleic acids, and chassis organism), and geography (North America, Europe, Asia, and Rest of World (ROW)). This segmentation provides a comprehensive view of the market, encompassing diverse communication solutions and regions. Furthermore, it examines key trends shaping the healthcare industry landscape and identifies potential challenges faced by market players. To get insights into the key trends, download the sample report here!The major Global Synthetic Biology Market companies include Agilent Technologies Inc., Algenol, Amyris Inc., CD Biosynsis, Codexis Inc., Creative Biogene, Eurofins Scientific SE, Genomatica Inc., GenScript Biotech Corp., Ginkgo Bioworks Holdings Inc., Illumina Inc., Merck KGaA, Novozymes AS, Sanofi SA, Twist Bioscience Corp. and Danaher Corp.These companies are actively implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product launches, to enhance their presence and competitiveness in Global Synthetic Biology Market.The Global Synthetic Biology Market is driven by its diverse applications across industries and the potential to address pressing challenges such as food production and healthcare. The market's expansion is underpinned by its capacity to optimize product efficiency and yield, though it faces obstacles arising from the complex nature of biological systems and evolving regulatory landscapes. As governments worldwide establish guidelines and policies, the market stands to benefit from increased investments, innovation, and safety assurance. Notably, the healthcare sector emerges as a pivotal growth driver, while North America holds a prominent position due to substantial investments and research endeavors. The synthetic biology market's journey forward will be defined by innovative solutions, regulatory alignment, and ongoing scientific advancements, paving the way for transformative contributions across various industries.Technavio provides a report that includes competitive intelligence, highlighting major players' key developments and growth strategies, enabling stakeholders to make informed decisions and stay competitive in the market. To buy the complete report on Global Synthetic Biology Market, click here.Below, are other reports you might be interested with:Molecular Biology Enzymes, Kits, and Reagents Market: The molecular biology enzymes, kits, and reagents market share are expected to increase by USD 13.09 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 14.61%. This report covers molecular biology enzymes, kits, and reagents market segmentation by end-user (biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations) and geography (North America, Europe, Asia, and ROW).Glycobiology Market: The glycobiology market share is expected to increase by USD 1.13 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 14.84%. The report covers glycobiology market segmentation by application (drug discovery and development, disease diagnostics, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)).).About Technavio:Technavio is a trusted source for industry news and insights that help businesses stay ahead in today's competitive landscape. With a team of experienced analysts and researchers, we continuously scrutinize and evaluate the dynamic landscape of markets across the globe. Our comprehensive coverage, meticulous research methodologies, and pragmatic industry expertise have earned us the trust and reliance of a vast clientele, including over 100 esteemed Fortune 500 organizations.SOURCE Technavio"
